March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC
Mar 29, 2025, 12:57

Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC

Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared a post on X:

“Now out.

COCOON: Preventing Moderate to Severe Dermatologic Adverse Events in First-line EGFR-mutant Advanced NSCLC Treated with Amivantamab Plus Lazertinib.

Presented by Nicolas Girard.

AEs ≥G2: OR 0.19 (95% CI, 0.09–0.40)

NCT06120140.”

Read further.

Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC

More posts featuring Hidehito Horinouchi.